Machine Learning

Amid intense market volatility, firms are turning to AI-powered energy storage to protect profits. One company's $53M deal shows how it's done.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

Amid soaring uranium prices, Refined Energy begins its maiden drill program in Saskatchewan's prolific Athabasca Basin, a high-stakes bet on nuclear's future.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

A new era in hearing arrives with Cochlear's Nexa System, the world's first upgradeable implant, tackling India's vast auditory health challenges.

In a strategic reverse merger with Rallybio, T-cell therapy innovator Candid Therapeutics secures over $505M to advance its groundbreaking autoimmune pipeline.

In a strategic move, CCC Intelligent Solutions adds former Salesforce and Informatica exec John Schweitzer to its board, signaling a major push in AI and data.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

With a strong cash position and promising drug candidate, Apogee Therapeutics is advancing multiple trials to challenge the I&I market with a new therapy.

Amid soaring cyber-attack costs in Asia, cloud security firm Upwind is tripling its workforce and deploying local infrastructure to deliver real-time protection.

ProCap Financial is making waves, buying 450 Bitcoin while aggressively repurchasing its own stock to close a valuation gap. A new corporate playbook?

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.